|
|
|
%20LIMITED%20-%20501617%2003-Apr-2018_files/image002.jpg){kind=small}
%20LIMITED%20-%20501617%2003-Apr-2018_files/image004.jpg)
%20LIMITED%20-%20501617%2003-Apr-2018_files/image005.gif)
MIRA INFORM REPORT
|
Report No. : |
501617 |
|
Report Date : |
03.04.2018 |
IDENTIFICATION DETAILS
|
Name : |
AHLCON PARENTERALS (INDIA) LIMITED (w.e.f. 03.08.1993) |
|
|
|
|
Formerly Known
As : |
GUJARAT INJECT (RAJASTHAN) LIMITED |
|
|
|
|
Registered
Office : |
Plot No. 30 & 30/E, 2nd Floor, Shivaji Marg, Najafgarh Road, Industrial
Area, New Delhi – 110015 |
|
Tel. No.: |
91-11-42344234, 42344218 /42344217 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 |
|
|
|
|
Date of
Incorporation : |
20.01.1992 |
|
|
|
|
Com. Reg. No.: |
55-047245 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 72.002 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239DL1992PLC047245 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Divulged |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACA1112C |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Divulged |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
08AAACA1112C1ZN |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
· Manufacturer of Pharmaceutical Intravenous Fluids, Opthalmics and others · Manufacturer of Allopathic Pharmaceutical Preparations (Registered Activity) |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 1640000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a subsidiary of “B Braun Singapore Pte. Limited” incorporated in the year 1992 and it is having satisfactory track record. It was originally known as “Gujarat Inject (Rajasthan) Limited” and later in the year 1993, the name was changed to “Ahlcon Parenterals (India) Limited”. The subject is engaged as manufacturer of pharmaceutical intravenous fluids and ophthalmic/ear drops. For the financial year 2017, the company has achieved decent growth in its revenue as compared to its previous year but has incurred loss during the year. Rating takes into consideration, the satisfactory financial risk profile marked by adequate net worth base and strong debt protection metrics. Rating continue to derive strength from its long and established track record of its business operation backed by its extensive experience of its promoters and strong financial support from its holding entity. However, these rating strength gets partially offset by continuous operational losses due to working capital intensive nature of operations, inherent commodity price risk associated with its trading operations, regulatory policy and competitive industry. Payments seems to be slow but correct. In view of aforesaid, the company can be considered for business dealing at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 03.04.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
Management non-cooperative (Tel No.: 91-11-42344217/ 91-1493-305300)
LOCATIONS
|
Registered Office : |
Plot No. 30 & 30/E, 2nd Floor, Shivaji Marg, Najafgarh Road,
Industrial Area, New Delhi – 110015, India |
|
Tel. No.: |
91-11-42344234, 42344218 /42344217 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Production Unit : |
SP-917 & 918, Phase - III, RIICO Industrial Area, Bhiwadi, District Alwar-301 019, Rajasthan, India |
|
Tel. No.: |
91-1493-305300 (30 Lines) |
|
Fax No.: |
91-1493-305345 |
|
E-Mail : |
DIRECTORS
As on 31.03.2017
|
Name : |
Mr. Indranil Mukherjee |
||||||||||||||||
|
Designation : |
Managing Director |
||||||||||||||||
|
Address : |
A-204, Sahayog HSG Complex, Tikujini Wadi Road, Thane (West), Thane
400610, Maharashtra, India |
||||||||||||||||
|
Date of Appointment : |
18.08.2017 |
||||||||||||||||
|
DIN No.: |
06692898 |
||||||||||||||||
|
Other
Directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Shiv Charan Lal Gupta |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
S-23/3, DLF, Phase III, Gurugram - 122002, Haryana, India |
||||||||||||||||
|
Date of Birth/Age : |
21.07.1957 |
||||||||||||||||
|
Qualification : |
MBBS,MD,MISCO |
||||||||||||||||
|
Date of Appointment : |
29.01.2003 |
||||||||||||||||
|
DIN No.: |
00359155 |
||||||||||||||||
|
Other
Directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Arun Kumar Gupta |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
M-14, Kailash Colony, New Delhi - 110048, India |
||||||||||||||||
|
Date of Birth/Age : |
27.12.1949 |
||||||||||||||||
|
Qualification : |
MISCO FCA, ICWA |
||||||||||||||||
|
Date of Appointment : |
15.03.1993 |
||||||||||||||||
|
DIN No.: |
00371289 |
||||||||||||||||
|
Other
Directorship:
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Suninder Singh Arora |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
91- Friends Colony Mathura Road, New Delhi - 110065, India |
||||||||||||||||
|
Date of Birth/Age : |
16.01.1969 |
||||||||||||||||
|
Qualification : |
MBBS, MD |
||||||||||||||||
|
Date of Appointment : |
31.01.2002 |
||||||||||||||||
|
DIN No.: |
00371867 |
||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Mr. Andreas Walde |
||||||||||||||||
|
Designation : |
Director |
||||||||||||||||
|
Address : |
521D-33A-01,The Cove, Jalan Tg. Bungah Tanjung Bunga, Penang 11200 MY |
||||||||||||||||
|
Date of Appointment : |
18.03.2016 |
||||||||||||||||
|
DIN No.: |
07331893 |
||||||||||||||||
|
|||||||||||||||||
|
|
|
||||||||||||||||
|
Name : |
Christoph Mueller |
||||||||||||||||
|
Designation : |
Additional Director |
||||||||||||||||
|
Address : |
Marriott Executive Apartment - Lakeside Chalet, 2 and 3B Near Chinmayanand
Ashram, Powai, Mumbai-400087, Maharashtra, India |
||||||||||||||||
|
Date of Appointment : |
23.11.2017 |
||||||||||||||||
|
DIN No.: |
08000451 |
||||||||||||||||
|
|||||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. Ranjan Kumar Sahu |
|
Designation : |
Company Secretary |
|
Address : |
Flat No.8a/D4, L I G Flat, Udyog Vihar Sector-82, Noida – 201305, Haryana, India |
|
Date of Birth/Age : |
06.01.1989 |
|
Date of Appointment : |
01.12.2007 |
|
PAN No.: |
ATDPS7346D |
MAJOR SHAREHOLDERS
As on 31.03.2017
SHAREHOLDING DETAILS FILE ATTACHED
Equity Share Break up (Percentage of Total Equity)
As on 27.09.2017
|
Category |
Percentage |
|
Promoters (Body corporate) |
96.12 |
|
Public/Other than promoters (Individual/Hindu Undivided Family – Indian) |
3.73 |
|
Public/Other than promoters (Body corporate) |
0.14 |
|
Public/Other than promoters (Others) |
0.01 |
|
Total |
100.00 |
%20LIMITED%20-%20501617%2003-Apr-2018_files/image006.gif)
BUSINESS DETAILS
|
Line of Business : |
· Manufacturer of Pharmaceutical Intravenous Fluids, Opthalmics and others · Manufacturer of Allopathic Pharmaceutical Preparations (Registered Activity) |
||||||||
|
|
|
||||||||
|
Products / Services
: |
|
||||||||
|
|
|
||||||||
|
Brand Names : |
Not Available |
||||||||
|
|
|
||||||||
|
Agencies Held : |
Not Available |
||||||||
|
|
|
||||||||
|
Exports : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Imports : |
Not Divulged |
||||||||
|
|
|
||||||||
|
Terms : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
Not Divulged |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
Arun K. Gupta and Associates Chartered Accountants |
|
Address : |
D-58, East of
Kailash, New Delhi – 110065, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AAFFA5512J |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Immediate Holding
company : |
B. Braun Singapore Pte. Limited, Singapore |
|
|
|
|
Holding company : |
B. Braun Medical Industries Sdn. Bhd., Malaysia |
|
|
|
|
Ultimate Holding
company: |
B. Braun Melsungen AG, Melsungen |
|
|
|
|
Parent of Ultimate
Holding Company : |
B Braun Holding GmbH and Co. KG, Germany |
|
|
|
|
Associates : |
B. Braun Medical (India) Private Limited CIN No.: U33112MH1984PTC214514 |
|
|
|
|
Enterprises which are
owned, or have significant influence of or are partners with Key management
personnel and their relatives : |
Oyster Medisafe Private Limited CIN No.: U33112TG2005PTC048100 |
CAPITAL STRUCTURE
As on 27.09.2017
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
11000000 |
Equity Shares |
INR 10/- each |
INR 110.000 Million |
|
7000000 |
Preference Shares |
INR 10/- each |
INR 70.000 Million |
|
|
Total |
|
INR 180.000
Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
7200150 |
Equity Shares |
INR 10/- each |
INR 72.002 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
72.002 |
72.002 |
72.002 |
|
(b) Reserves and Surplus |
502.648 |
640.876 |
826.206 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
574.650 |
712.878 |
898.208 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
1000.000 |
1820.751 |
1817.641 |
|
(b) Deferred tax liabilities (Net) |
0.000 |
0.000 |
53.316 |
|
(c) Other long-term
liabilities |
2.660 |
3.740 |
1.748 |
|
(d) long-term
provisions |
10.584 |
8.889 |
9.859 |
|
Total Non-current
Liabilities (3) |
1013.244 |
1833.380 |
1882.564 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short-term
borrowings |
1735.735 |
686.224 |
243.997 |
|
(b) Trade
payables |
41.410 |
63.730 |
76.041 |
|
(c) Other
current liabilities |
252.463 |
281.649 |
278.122 |
|
(d) Short-term provisions |
11.551 |
11.373 |
4.433 |
|
Total Current
Liabilities (4) |
2041.159 |
1042.976 |
602.593 |
|
|
|
|
|
|
TOTAL |
3629.053 |
3589.234 |
3383.365 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
2743.018 |
2882.933 |
2765.179 |
|
(ii)
Intangible Assets |
7.368 |
9.407 |
12.007 |
|
(iii) Tangible assets
capital work-in-progress |
274.547 |
108.333 |
32.121 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d)
Long-term loans and advances |
43.193 |
43.438 |
34.932 |
|
(e) Other
Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current
Assets |
3068.126 |
3044.111 |
2844.239 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
170.656 |
215.214 |
136.054 |
|
(c) Trade
receivables |
332.137 |
261.239 |
312.967 |
|
(d) Cash and
bank balances |
5.320 |
17.568 |
8.615 |
|
(e)
Short-term loans and advances |
18.065 |
20.969 |
48.520 |
|
(f) Other
current assets |
34.749 |
30.133 |
32.970 |
|
Total
Current Assets |
560.927 |
545.123 |
539.126 |
|
|
|
|
|
|
TOTAL |
3629.053 |
3589.234 |
3383.365 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SALES |
|
|
|
|
|
Revenue
from operations |
1353.892 |
1189.974 |
1159.838 |
|
|
Other Income |
6.099 |
4.201 |
3.858 |
|
|
TOTAL |
1359.991 |
1194.175 |
1163.696 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
418.449 |
471.394 |
425.887 |
|
|
Purchases of
Stock-in-Trade |
0.000 |
0.000 |
0.000 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
46.005 |
(65.098) |
(14.133) |
|
|
Employee benefit expense |
245.605 |
224.468 |
176.735 |
|
|
Other expenses |
452.197 |
474.161 |
313.963 |
|
|
TOTAL |
1162.256 |
1104.925 |
902.452 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION |
197.735 |
89.250 |
261.244 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
172.943 |
165.678 |
6.282 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
24.792 |
(76.428) |
254.962 |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
163.020 |
161.283 |
46.076 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
BEFORE TAX |
(138.228) |
(237.711) |
208.886 |
|
|
|
|
|
|
|
Less |
TAX |
0.000 |
(52.381) |
38.722 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS)
AFTER TAX |
(138.228) |
(185.330) |
170.164 |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
231.027 |
204.399 |
377.664 |
|
|
TOTAL EARNINGS |
231.027 |
204.399 |
377.664 |
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
Raw Materials |
181.348 |
198.002 |
212.411 |
|
|
Components and spare
parts |
11.920 |
7.339 |
2.451 |
|
|
Capital Goods |
7.957 |
47.644 |
837.643 |
|
|
TOTAL IMPORTS |
201.226 |
252.985 |
1052.504 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
(19.20) |
(25.74) |
23.63 |
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
0.238 |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
132.088 |
82.457 |
377.754 |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
89.54 |
80.13 |
98.49 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry
Debtors) |
4.08 |
4.56 |
3.71 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors
/ Purchases * 365 Days) |
36.12 |
49.35 |
65.17 |
|
|
|
|
|
|
Inventory Turnover (Operating Income
/ Inventories) |
1.16 |
0.41 |
1.92 |
|
|
|
|
|
|
Asset Turnover (Operating Income
/ Net Fixed Assets) |
0.07 |
0.03 |
0.09 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total
Assets) |
0.84 |
0.80 |
0.72 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability /
Networth) |
4.76 |
3.52 |
2.30 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
3.55 |
1.46 |
0.67 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets
/ Networth) |
5.26 |
4.21 |
3.13 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial
Charges) |
1.14 |
0.54 |
41.59 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) *
100) |
% |
(10.21) |
(15.57) |
14.67 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total
Assets) * 100) |
% |
(3.81) |
(5.16) |
5.03 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth)
* 100) |
% |
(24.05) |
(26.00) |
18.94 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
0.27 |
0.52 |
0.89 |
|
|
|
|
|
|
Quick Ratio ((Current Assets
– Inventories) / Current Liabilities) |
0.19 |
0.32 |
0.67 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total
Assets) |
0.16 |
0.20 |
0.27 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity
Capital) |
38.00 |
34.82 |
28.64 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current
Assets / Total Current Liabilities) |
0.27 |
0.52 |
0.89 |
Total Liability = Short-term Debt + Long-term
Debt + Current Maturities of Long-term debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Share Capital |
72.002 |
72.002 |
72.002 |
|
Reserves & Surplus |
826.206 |
640.876 |
502.648 |
|
Net
worth |
898.208 |
712.878 |
574.650 |
|
|
|
|
|
|
long-term borrowings |
1817.641 |
1820.751 |
1000.000 |
|
Short term borrowings |
243.997 |
686.224 |
1735.735 |
|
Total
borrowings |
2061.638 |
2506.975 |
2735.735 |
|
Debt/Equity
ratio |
2.295 |
3.517 |
4.761 |
%20LIMITED%20-%20501617%2003-Apr-2018_files/image007.gif)
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
1159.838 |
1189.974 |
1353.892 |
|
|
|
2.598 |
13.775 |
%20LIMITED%20-%20501617%2003-Apr-2018_files/image008.gif)
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
(INR
In Million) |
(INR
In Million) |
(INR
In Million) |
|
Sales |
1159.838 |
1189.974 |
1353.892 |
|
Profit/ (Loss) |
170.164 |
(185.330) |
(138.228) |
|
14.67% |
(15.57%) |
(10.21%) |
%20LIMITED%20-%20501617%2003-Apr-2018_files/image009.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of establishment |
Yes |
|
2] |
Constitution of the entity Incorporation
details |
Yes |
|
3] |
Locality of the entity |
Yes |
|
4] |
Premises details |
No |
|
5] |
Buyer visit details |
-- |
|
6] |
Contact numbers |
Yes |
|
7] |
Name of the person contacted |
No |
|
8] |
Designation of contact person |
No |
|
9] |
Promoter’s background |
Yes |
|
10] |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11] |
Pan Card No. of Proprietor / Partners |
No |
|
12] |
Voter Id Card No. of Proprietor / Partners |
No |
|
13] |
Type of business |
Yes |
|
14] |
Line of Business |
Yes |
|
15] |
Export/import details (if applicable) |
No |
|
16] |
No. of employees |
No |
|
17] |
Details of sister concerns |
Yes |
|
18] |
Major suppliers |
No |
|
19] |
Major customers |
No |
|
20] |
Banking Details |
No |
|
21] |
Banking facility details |
Yes |
|
22] |
Conduct of the banking account |
-- |
|
23] |
Financials, if provided |
Yes |
|
24] |
Capital in the business |
Yes |
|
25] |
Last accounts filed at ROC, if applicable |
Yes |
|
26] |
Turnover of firm for last three years |
Yes |
|
27] |
Reasons for variation <> 20% |
-- |
|
28] |
Estimation for coming financial year |
Yes |
|
29] |
Profitability for last three years |
Yes |
|
30] |
Major shareholders, if available |
Yes |
|
31] |
External Agency Rating, if available |
No |
|
32] |
Litigations that the firm/promoter
involved in |
-- |
|
33] |
Market information |
-- |
|
34] |
Payments terms |
No |
|
35] |
Negative Reporting by Auditors in the
Annual Report |
No |
NATURE OF OPERATIONS
The Company is the manufacturer of Pharmaceutical Intravenous Fluids, Opthalmics and others
OPERATIONAL
PERFORMANCE
The Directors present the Operational performance of the company, which in the company has achieved a sales turnover of INR 1353.800 Million (net of excise) as compared to the previous year sales turnover of INR 1190.000 Million (net of excise) hereby register a growth of 13.76%.
The company's Net Loss during the year recorded INR 138.228 Million as compare to previous year figure profit of INR 185.330 Million, due to price discrimination, cut throat competition, entry of new entities in the market, government price regulatory mechanism and delay of execution of the initial phase of new plant leading to an additional depreciation and interest cost on the operational performance.
Directors are putting constant thrust on productivity enhancement, cost optimization and customer satisfaction by producing their quality products enabling continuous growth track, in the operational results of the company.
UNSECURED LOAN
|
PARTICULAR |
31.03.2017 (INR
in Million) |
31.03.2016 (INR
in Million) |
|
Long-term
Borrowings |
|
|
|
Deferred payment liabilities |
0.000 |
820.751 |
|
Short-term
borrowings |
|
|
|
Deferred payment liabilities |
818.471 |
0.000 |
|
Total |
818.471 |
820.751 |
INDEX
OF CHARGES
|
S No |
SRN |
Charge Id |
Charge Holder Name |
Date of Creation |
Date of Modification |
Date of Satisfaction |
Amount |
Address |
|
1 |
Y10128993 |
90048898 |
ALLAHABAD BANK |
11/02/2002 |
18/12/2002 |
- |
100000000.0 |
17/90; MADRAS COMPLEX INDUSTRIAL FINANCE BRANCH; CONNAUGHT CIRCUS NEW DELHI INDIA |
|
2 |
Y10126625 |
90046530 |
THE ALLAHABAD BANK |
22/02/1996 |
06/09/2001 |
- |
46000000.0 |
17/90; MADRAS COMPLEX INDUSTRIAL FINANCE BRANCH; CONNAUGHT CIRCUS NEW DELHI INDIA |
|
3 |
C12685301 |
10214300 |
PUNJAB & SIND BANK |
25/03/2010 |
- |
03/07/2014 |
211100000.0 |
H BLOCK, CONNSUGHT CIRCUS NEW DELHI 110001 INDIA |
|
4 |
C12686200 |
10214302 |
PUNJAB & SIND BANK |
25/03/2010 |
02/09/2011 |
03/07/2014 |
358500000.0 |
H BLOCK, CONNSUGHT CIRCUS NEW DELHI 110001 INDIA |
|
5 |
C12686960 |
10214298 |
PUNJAB & SIND BANK |
25/03/2010 |
- |
03/07/2014 |
40000000.0 |
H BLOCK, CONNSUGHT CIRCUS NEW DELHI 110001 INDIA |
|
6 |
C12684494 |
10214301 |
PUNJAB & SIND BANK |
25/03/2010 |
02/09/2011 |
03/07/2014 |
130000000.0 |
H BLOCK, CONNSUGHT CIRCUS NEW DELHI 110001 INDIA |
|
7 |
A85524528 |
80028969 |
Syndicate Bank |
22/10/2005 |
11/04/2007 |
19/05/2010 |
370000000.0 |
Corporate Finance Branch,Delhi Tamil Sangam Building, R K Puram New Delhi 110022 INDIA |
|
8 |
A85655231 |
80028970 |
Syndicate Bank |
23/11/2004 |
11/04/2007 |
19/05/2010 |
370000000.0 |
Corporate Finance Branch,Delhi Tamil Sangam Building, R K Puram New Delhi 110022 INDIA |
CONTINGENT
LIABILITIES:
|
PARTICULARS |
31.03.2017 (INR
in Million) |
31.03.2016 (INR
in Million) |
|
Claims against company not acknowledged as debt |
178.185 |
174.069 |
|
Guarantees |
7.260 |
14.534 |
|
Total |
185.445 |
188.603 |
FIXED ASSETS
·
Land
·
Buildings
·
Plant and Equipment
·
Furniture and Fixtures
·
Vehicles
·
Office Equipment
·
Computer Equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 65.04 |
|
UK Pound |
1 |
INR 92.28 |
|
Euro |
1 |
INR 80.62 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
NIS |
|
|
|
|
Report Prepared
by : |
JYTK |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.
·